Duncan Edmonstone

@edmonstone.net

UK-based lung cancer patient advocate. Used to work in IT. Progressive. (Don’t try and visit edmonstone.net there’s nothing there right now)

It’s World Lung Cancer Day 2026. It’s also exactly 7 years since I had surgery to remove a metastatic tumour from my brain caused by my own lung cancer. I got this rather fetching scar! 1/n

Bild

I’m not really one for bucket lists, but if I was, seeing the godfathers of electronic music, Kraftwerk at the Royal Albert Hall would have been right up there. Absolutely amazing show. Can I go again please?

Won an award at the Greater Manchester Cancer Alliance Awards - this was the Patient's Choice award for the work I do as a patient advocate for the alliance. I don't care too much about recognition, but it is nice to know you are making a difference, however small. #GMCancerAwards26

Photograph of me (Duncan Edmonstone) accepting the Patient Choice award at the GM Cancer Alliance Awards 2026. Also in the photograph are two members of the Alliance's User Involvement team and the events host, comedian John Thomson

📣 The April NLCA Newsletter is here! This month features the recently published State of the Nation report 2026, the upcoming April Data Dashboard, and engagement activities including our latest blog, conference participation and upcoming podcast.  👉 Read here: buff.ly/4uAhrxe @btog.bsky.social

NLCA Newsletter, April 2026 - National Cancer Audit Collaborating Centre

We use some essential cookies to make this website work.

natcan.org.uk

Last night I attended the launch of the Greater Manchester Cancer Alliance Metastatic Strategy. Metastatic patients often “fall through the cracks” between healthcare teams or experience poor communication from those teams. 1/n

Positive news emerging about Nuvalent's 4G TKI for ALK+ NSCLC patients. Latest trial result show 31% of all patients had a complete or partial response (many of these were heavily pre-treated with other TKIs and chemo). For patients who never received Lorlatinib this increased to 46% 1/n

Amazing mOS figures from the final trial report of the drug I happen to take... and there are better drugs on the market now and in phase 3 trials. Reassuring to know how fast treatments are improving in the ALK+ NSCLC space #LCSM #CANSKY

Dr Mathew Wilson@mathewgwilson.bsky.social · 10mo ago

#ALEX study shows 81.1 month median OS in final report of study from Tong Mok Amongst the longest overall survivals reported in lung cancer. Further trials of 3rd and 4th gen TKI ongoing. Much work to do, but valuable to reflect on how far things have com #ESMO25 #LCSM #Alk #NSCLC

Sigh... suspended from Facebook by their dumb AI algorithm No big deal right? For me, it cuts me off from all of my cancer support groups, hosted on the platform. Can't contact anyone directly at Meta to appeal... "services" to help you get your account back are scammers... not my first rodeo!

Bild